NCT00974740 - DIATOR-Diabetes Intervention With Atorvastatin | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

January 31, 2008

Study Completion Date

March 31, 2009

Conditions

Type 1 Diabetes

Interventions

DRUG

Atorvastatin

atorvastatin 40 mg (tablet for oral intake) once daily in the evening for 4 weeks, thereafter 80 mg for the remaining treatment period (total treatment period 18 months)

DRUG

atorvastatin matching placebo

atorvastatin matching placebo tablets once daily in the evening, corresponding to 40 mg atorvastatin for the first 4 weeks (run-in period), and corresponding to 80 mg atorvastatin thereafter (total treatment period 18 months)

Trial Locations (12)

14089

Gemeinschaftskrankenhaus Havelhöhe, Berlin

14165

Helios Klinikum Emil von Behring, Berlin

40221

DDZ Deutsches Diabetes Zentrum, Düsseldorf

45770

Praxis Dr. Heinz-Georg Ley, Marl

48145

Diabetologische Schwerpunktpraxis, Angiologie, Münster

50968

St. Antonius Krankenhaus, Med. Klinik, Cologne

51373

Praxis Dr. Gerhard Willms, Leverkusen

59909

Praxis Dr. Friedhelm Schmitten, Bestwig-Ramsbeck

69115

St. Josefs Krankenhaus, Heidelberg

97070

Praxis Dr. Werner Stürmer, Würzburg

97980

Diabetes-Zentrum Mergentheim, Bad Mergentheim

04103

Praxisklinik Leipzig, Leipzig